There have been many recent advancements in glaucoma surgery. Traditionally, glaucoma surgeries were invasive procedures prone to moderate amounts of risks, complications, and need for repeat surgeries. In recent years, newer techniques and devices have emerged and have been given the name Minimally Invasive Glaucoma Surgery (MIGS).
MIGS surgeries have the advantages of helping to lower eye pressure, but with much less risks of complications compared to traditional glaucoma surgeries, such as trabeculectomy and tube shunt. MIGS procedures typically only last 5-10 minutes and are performed without the need for general anesthesia or intubation. The surgeries are comparable to cataract surgery as far as recovery and tolerability.
Azar Eye Clinic was the first eye clinic in Lafayette, LA and Acadiana to begin implanting the iStent, one of the leading MIGS devices on the market. The iStent is the smallest implant that is FDA approved to be placed into the human body. The original iStent has been replaced by the iStent Inject which offers improvements over the original iStent design.